252 related articles for article (PubMed ID: 30530521)
1. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.
Dong Y; Wang X; Zhang L; Chen Z; Zheng C; Wang J; Kang Y; Shao L; Tian Y; Wang Z;
J Epidemiol Community Health; 2019 Feb; 73(2):188-192. PubMed ID: 30530521
[TBL] [Abstract][Full Text] [Related]
2. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
3. [Association between high-sensitivity C-reactive protein and both cardiovascular, total mortality events in middle-aged Chinese adults].
Dong Y; Wang ZW; Wang X; Tian Y; Zhang LF; Chen Z; Cao HQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):428-432. PubMed ID: 29699031
[No Abstract] [Full Text] [Related]
4. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.
Wilson PW; Pencina M; Jacques P; Selhub J; D'Agostino R; O'Donnell CJ
Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):92-7. PubMed ID: 20031795
[TBL] [Abstract][Full Text] [Related]
6. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Cummings DM; King DE; Mainous AG; Geesey ME
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
[TBL] [Abstract][Full Text] [Related]
7. Distribution of High-Sensitivity C-Reactive Protein and Its Relationship with Other Cardiovascular Risk Factors in the Middle-Aged Chinese Population.
Wang Z; Wang X; Chen Z; Zhang L; Zhu M
Int J Environ Res Public Health; 2016 Aug; 13(9):. PubMed ID: 27589783
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
Zhu K; Knuiman M; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Hung J
Heart; 2018 Jun; 104(11):895-903. PubMed ID: 29066610
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study.
Yang EY; Nambi V; Tang Z; Virani SS; Boerwinkle E; Hoogeveen RC; Astor BC; Mosley TH; Coresh J; Chambless L; Ballantyne CM
J Am Coll Cardiol; 2009 Dec; 54(25):2388-95. PubMed ID: 20082929
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population.
Jiang S; Bao Y; Hou X; Fang Q; Wang C; Pan J; Zuo Y; Zhong W; Xiang K; Jia W
Am J Cardiol; 2009 Jun; 103(12):1727-31. PubMed ID: 19539083
[TBL] [Abstract][Full Text] [Related]
13. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis.
Schlager O; Exner M; Mlekusch W; Sabeti S; Amighi J; Dick P; Wagner O; Koppensteiner R; Minar E; Schillinger M
Stroke; 2007 Apr; 38(4):1263-8. PubMed ID: 17322087
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
16. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
[TBL] [Abstract][Full Text] [Related]
17. High sensitivity C-reactive protein as a cardiovascular risk marker in independent community-living elderly persons.
Płóciniczak A; Dzięgielewska-Gęsiak S; Brożek A; Blacha A; Nowicki M; Formanowicz D
J Biol Regul Homeost Agents; 2018; 32(5):1199-1204. PubMed ID: 30334413
[TBL] [Abstract][Full Text] [Related]
18. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein: adjunct to cardiovascular risk assessment.
Bahadursingh S; Beharry K; Maharaj K; Mootoo C; Sharma P; Singh J; Teelucksingh K; Tilluckdharry R
West Indian Med J; 2009 Dec; 58(6):551-5. PubMed ID: 20583681
[TBL] [Abstract][Full Text] [Related]
20. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study.
Aryan Z; Ghajar A; Faghihi-Kashani S; Afarideh M; Nakhjavani M; Esteghamati A
Ann Nutr Metab; 2018; 72(4):287-295. PubMed ID: 29694948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
